Lipoproteinuria As an Independent Predictor of Unfavorable Outcome After Intravenous Thrombolysis in Ischaemic Stroke
DOI:
https://doi.org/10.61788/njn.v2i14.01Keywords:
ischaemic stroke, cerebrorenal disfunction, proteinuria, glomerular filtration rate, intravenous thrombolysis, hemorrhagic transformationAbstract
Patients with proteinuria and declined glomerular filtration rate (GFR) are at high risk of developing stroke. Purpose of this study was to review and analyze available literature to identify role of proteinuria along with decreased GFR as one the of predictors of unfavorable outcome of ischaemic stroke in patients receiving intravenous thrombolysis therapy in routine clinical practice. Proteinuria is an independent predictor of negative outcome after intravenous thrombolysis treatment in ischaemic stroke, which demonstrates significant impact of chronic kidney disorders in effectiveness of thrombolytic therapy.
References
Бобкова И.Н., Чеботарева Н.В., Ремаев В.В. Роль эндотелиальной дисфункции в прогрессировании хронического гломерулонефрита, современные возможности ее коррекции // Тер. архив. - 2005. - №6. - С.92.
Верещагин Н.В., Суслина З.А. Определение вероятностей подтипов ишемического инсульта. - 2004. - www.stroke-center.ru.
Даминов Б.Т., Эгамбердиева Д.А., Абдуллаев Ш.С. Клиническое значение артериальной гипертензии у больных с диабетической нефропатией // Мед. журн. Узбекистана. - 2010. - №4. - С. 56-60.
Даминов Б.Т., Эгамбердиева Д.А., Рузметова И.А., Абдуллаев Ш.С. Оценка фукционального состояния сердца и почек у пациентов с ренальной дисфункцией при наличии и отсутствии у них диабетической нефропатии // Журн. теорет. и клинич. медицины. - Ташкент, 2011. №5. С.26-30.
Камилова У.К., Расулова З.Д., Нурматова Д.Б. Оценка функционального состояния почек у больных с хронической сердечной недостаточностью. - Метод. пособие, Ташкент, 2013. - 27 с.
Маджидова Ё.Н., Расулова Х.А. Ишемический инсульт (инфаркт мозга): клиника, диагностика, лечение. - Руководство, Ташкент, 2011. - 232 с.
Расулова Х.А. Некоторые молекулярные механизмы развития ишемического инсульта // Межд. мед. журн. - 2013. - Т.19, №3(75). - С. 22-29.
Суслина З.А., Варакин Ю.А., Верещагин Н.В. Сосудистые заболевания головного мозга: Эпидемиология. Патогенетические механизмы. Профилактика - 2-е изд., доп. и перераб. - М., 2009. - 352 с.
Adams H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B. et al. Classification of subtype of acute ischaemic stroke. Definitions for use in a multicenter clinical trial. TOAST Trial of Org 10172 in Acute Stroke Treatment // Stroke. - 1993. - Vol. 24. - P. 35-41.
Agrawal V., Marinescu V., Agarwal M., McCullough P.A. Cardiovascular implications of proteinuria: an indicator of chronic kidney disease // Nat Rev Cardiol. - 2009.- Vol. 6. - P. 301-311.
Agrawal V., Rai B., Fellows J., McCullough P.A. Inhospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke // Nephrol Dial Transplant. - 2010. - Vol. 25. - P. 1150-1157.
Bonita R. Epidemiology of stroke // Lancet. - 1992. - Vol. 339. - Р. 342-344.
Brosius F.C., Hostetter T.H., Kelepouris E., Mitsnefes M.M., Moe S.M. et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation // Circulation. - 2006. - Vol. 114. - P. 1083-1087.
Chao A.C., Hsu H.Y., Chung C.P., Liu C.H., Chen C.H. et al. Outcomes of thrombolytic therapy for acute ischaemic stroke in Chinese patients: the Taiwan Thrombolytic Therapy for Acute Ischaemic Stroke (TTTAIS) study // Stroke. - 2010. - Vol. 41. - P. 885-890.
Chen C.H., Tang S.C., Tsai L.K., Yeh S.J. et al. Proteinuria independently predicts unfavorable outcome of ischaemic stroke patients receiving intravenous thrombolysis // 2013 PLoS One. 2013; 8(11): e80527.
Cho B.H., Kim J.T., Chang J., Choi K.H., Park M.S., Cho K.H. Prediction of hemorrhagic transformation in acute ischaemic stroke by micro- and macroalbuminuria after intravenous thrombolysis // Eur J Neurol. - 2013. - Vol. 20. - P. 1145-1152.
Coresh J., Selvin E., Stevens L.A., Manzi J., Kusek J.W. et al. Prevalence of chronic kidney disease in the United States // JAMA. - 2007. - Vol. 298. - P. 2038-2047.
Daminov B.T., Abdullaev S.S. The effects of eprosartan mesylate and lercanidipine on reducing microalbuminuria in patients with nephropathy due to type 2 diabetes // International Journal of BioMedicine. - 2013. - Vol. 3(2). - P. 70-73.
Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., Jensen T., Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis // Diabetologia. - 1989. - Vol. 32. - P. 219-226.
El Nahas A.M., Bello A.K. Chronic kidney disease: the global challenge // Lancet. - 2005. - Vol. 365. - P. 331-340.
Fox K.A., Antman E.M., Montalescot G., Agewall S., SomaRaju B. et al. The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial // J Am Coll Cardiol. - 2007. - Vol. 49. - P. 2249-2255.
Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization // N Engl J Med. - 2004. - Vol. 351. - P. 1296-1305.
Hacke W., Kaste M., Bluhmki E. et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischaemic stroke // N Engl J Med. - 2002. - Vol. 359. - P. 1317-1329.
Jauch E.C., Saver J.L., Adams H.P., Bruno A., Connors J.J. et al. Guidelines for the early management of patients with acute ischaemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association // Stroke. - 2013. - Vol. 44. - P. 870-947.
Knobl P., Schernthaner G., Schnack C., Pietschmann P., Griesmacher A. et al. Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulindependent) and type 2 (non-insulin-dependent) diabetic patients // Diabetologia. - 1993. - Vol. 36. - P. 1045-1050.
Koren-Morag N., Goldbourt U., Tanne D. Renal dysfunction and risk of ischaemic stroke or TIA in patients with cardiovascular disease // Neurology. -2006. - Vol. 67. - P. 224-228.
Kumai Y., Kamouchi M., Hata J., Ago T., Kitayama J. et al. Proteinuria and clinical outcomes after ischaemic stroke // Neurology. - 2012. - Vol. 78. - P. 1909-1915.
Lee M., Saver J.L., Chang K.H., Liao H.W., Chang S.C., Ovbiagele B. Impact of microalbuminuria on incident stroke: a meta-analysis // Stroke. - 2010. - Vol. 41. - P. 2625-2631.
Lyrer P.A., Fluri F., Gisler D., Papa S., Hatz F., Engelter S.T. Renal function and outcome among stroke patients treated with IV thrombolysis // Neurology. - 2008. - Vol. 71. - P. 1548-1550.
MacWalter R.S., Wong S.Y., Wong K.Y., Stewart G., Fraser C.G. et al. Does renal dysfunction predict mortality after acute stroke? A 7-year follow-up study // Stroke. - 2002. - Vol. 33. - P. 1630-1635.
Madison J.R., Spies C., Schatz I.J., Masaki K., Chen R. et al. Proteinuria and risk for stroke and coronary heart disease during 27 years of follow-up: the Honolulu Heart Program // Arch Intern Med. - 2006. - Vol. 166. - P. 884-889.
Naganuma M., Koga M., Shiokawa Y., Nakagawara J., Furui E. et al. Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry // Cerebrovasc Dis. - 2011. - Vol. 31. - P. 123-129.
Ninomiya T., Perkovic V., Verdon C., Barzi F., Cass A. et al. Proteinuria and stroke: a meta-analysis of cohort studies // Am J Kidney Dis. - 2009. - Vol. 53. - P. 417-425.
Norris J.W., Buchan A., Cote R., Hachinski V., Phillips S.J. et al. Canadian guidelines for intravenous thrombolytic treatment in acute stroke. A consensus statement of the Canadian Stroke Consortium // Can J Neurol Sci. - 1998. - Vol. 25. - P. 257-259.
Ochodnicky P., Henning R.H., van Dokkum R.P., de Zeeuw D. Microalbuminuria and endothelial dysfunction: emerging targets for primary prevention of end-organ damage // J Cardiovasc Pharmacol. - 2006. - Vol. 47(2). - P. S151-S162.
Ovbiagele B. Microalbuminuria: risk factor and potential therapeutic target for stroke? // J Neurol Sci. - 2008. - Vol. 271. - P. 21-28.
Rodriguez-Yanez M., Castellanos M., Blanco M., Millan M., Nombela F. et al. Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischaemic stroke // Neurology. - 2006. - Vol. 67. - P. 1172-1177.
Sharma V.K., Tsivgoulis G., Tan J.H., Wong L.Y., Ong B.K. et al. Feasibility and safety of intravenous thrombolysis in multiethnic Asian stroke patients in Singapore // J Stroke Cerebrovasc Dis. - 2010. - Vol. 19. -P. 424-430.
Saposnik G., Fang J., Kapral M.K., Tu J.V., Mamdani M. et al. The iScore predicts effectiveness of thrombolytic therapy for acute ischaemic stroke // Stroke. - 2012. - Vol. 43. - P. 1315-1322.
Slowik A., Turaj W., Iskra T., Strojny J., Szczudlik A. Microalbuminuria in nondiabetic patients with acute ischaemic stroke: prevalence, clinical correlates, and prognostic significance // Cerebrovasc Dis. - 2002. - Vol. 14. - P. 15-21.
Tissue plasminogen activator for acute ischaemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group // N Engl J Med. - Vol. 333. - P. 1581-1587.
Toyoda K., Koga M., Naganuma M., Shiokawa Y., Nakagawara J. et al. Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients: general outcomes and prognostic factors from the SAMURAI register // Stroke. - 2009. - Vol. 40. - P. 3591-3595.
Wahlgren N., Ahmed N., Davalos A., Ford G.A., Grond M. et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study // Lancet. - 2007. - Vol. 369. - P. 275-282.
Wahlgren N., Ahmed N., Eriksson N., Aichner F., Bluhmki E. et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) // Stroke. - 2008. - Vol. 39. - P. 3316-3322.
Wardlaw J.M., Zoppo G., Yamaguchi T., Berge E. Thrombolysis for acute ischaemic stroke // Cochrane Database Syst Rev 3. - 2003. - CD000213.
Wen C.P., Cheng T.Y., Tsai M.K., Chang Y.C., Chan H.T. et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462-293 adults in Taiwan // Lancet. - 2008. - Vol. 371. - P. 2173-2182.
Yahalom G., Schwartz R., Schwammenthal Y., Merzeliak O., Toashi M. et al. Chronic kidney disease and clinical outcome in patients with acute stroke // Stroke. -2009. - Vol. 40. - P. 1296-1303.
Yuyun M.F., Khaw K.T., Luben R., Welch A., Bingham S. et al. Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study // J Intern Med. - 2004. - Vol. 255. - P. 247-256.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 National Association of Neurologists
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
